Error message

User warning: The following module is missing from the file system: admin_menu. For information about how to fix this, see the documentation page. in _drupal_trigger_error_with_delayed_logging() (line 1138 of /mnt/stor8-wc1-dfw1/408138/www.cannabissativa.co/web/content/includes/bootstrap.inc).

Cannabis & Hemp Stocks - Clinical Trials

 
05/17/2018 - 1:38pm
Here's Why Nektar Therapeutics Fell as Much as 11.1% Today
() The law of averages snuck up on one of the company's ongoing clinical trials.
https://finance.yahoo.com/news/apos-why-nektar-therapeutics-fell-173800191.html?...
05/17/2018 - 7:47am
APH.V
Cannabis is Fueling the Next Era of Medical Revolution
(Cannabis, CBD, Development, Distribution, Events, Food, Growing, Investment, Investments, Investors, Marketing, Media, Medical Marijuana, News, Pharmaceutical Grade, Production, Products, Research, Synthetic, Vaporizers, Vaporizers, Pharmaceuticals, Intellectual Property, Security) Talk of legalizing marijuana throughout North America has been growing like a weed. Up to 88% of Americans favor its medicinal use, thanks to a growing body of research supporting marijuana's use for medical purposes. Some studies even suggest it can be used for a variety of medical issues including pain, nausea, loss of appetite, Parkinson's disease, inflammatory bowel disease, post-traumatic stress disorder, epilepsy, and multiple sclerosis and even traumatic brain injuries - the list goes on. Several legitimate players in the medical marijuana sector include Scythian Biosciences Corporation (TSX-V: SCYB) (OTC: SCCYF) , GW Pharmaceuticals (NASDAQ: GWPH) , OrganiGram Holdings Inc. (TSX-V: OGI) (OTC: OGRMF) , Corbus Pharmaceuticals (NASDAQ: CRBP) and Aphria Inc. (OTC: APHQF) (TSX: APH) . As more than 29 U.S. states plus Washington, D.C. have approved its medicinal use, and as eight states have approved its recreational use, it's clear that legal marijuana stocks are here to stay. On...
https://www.reddit.com/r/weedstocks/comments/8k3mck/cannabis_is_fueling_the_next...
05/15/2018 - 8:00pm
CBDS
CBDs Cannabinoids & Cannabidiol (Episode #172) -
(CBD, Media, Products, Research, Science, Social Media) CBDs Cannabinoids & Cannabidiol (Episode #172) March 21st, 2018 thehealthyskeptics.com/ Stephen Cherniske and Dr. Natalie Kather are your Nutritional biochemist & M.D. Your personal biomedical team! Research, Experience and humor. Explore or Ignore!" Stephen Cherniske, M.S. A biochemist and former university instructor in Clinical Nutrition. He served on the faculty of the American College of Sports Medicine, advised members of the US Olympic team, and directed the nation’s first federally licensed clinical laboratory specializing in nutrition and immunology. A best-selling author with more than a million copies in print, Stephen has a remarkable gift for communicating breakthrough science that inspires, entertains and motivates. Natalie Kather, M.D. She received her medical degree from The University of Utah School of Medicine. She is board-certified in Family Medicine, as well as Anti-aging, with specialties in women’s health, hormone balancing and human performance. Natalie...
https://vimeo.com/269984357
05/15/2018 - 3:10pm
CBD Industry Update (Episode #200) -
(CBD, Media, Products, Research, Science, Social Media) CBD Industry Update (Episode #200) Monday May 14th, 2018 thehealthyskeptics.com/ Stephen Cherniske and Dr. Natalie Kather are your Nutritional biochemist & M.D. Your personal biomedical team! Research, Experience and humor. Explore or Ignore!" Stephen Cherniske, M.S. A biochemist and former university instructor in Clinical Nutrition. He served on the faculty of the American College of Sports Medicine, advised members of the US Olympic team, and directed the nation’s first federally licensed clinical laboratory specializing in nutrition and immunology. A best-selling author with more than a million copies in print, Stephen has a remarkable gift for communicating breakthrough science that inspires, entertains and motivates. Natalie Kather, M.D. She received her medical degree from The University of Utah School of Medicine. She is board-certified in Family Medicine, as well as Anti-aging, with specialties in women’s health, hormone balancing and human performance. Natalie is...
https://vimeo.com/269935661
05/15/2018 - 2:28pm
BMY, ENDP
Nektar Therapeutics Stock Is Risky But Offers Big Reward
(Investors) After topping the $110 level in March 2018, shares of Nektar Therapeutics (NASDAQ:NKTR) are in a downtrend. It is worth noting that even though Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Endo International PLC (NASDAQ:ENDP) are starting to attract investors, NKTR stock is more attractive because of the drug’s inherent properties. Nektar collaborated with Bristol-Myers Squibb Company (NYSE:BMY) to develop NKTR-214 in clinical trials.
https://finance.yahoo.com/news/nektar-therapeutics-stock-risky-offers-182800528....
05/15/2018 - 1:29pm
$HVT.v $HRVOF PTL anticipates both phase 2 clinical trials to be complete in the first half of 2018.
() https://www.harvestone.com/portfolio/satipharm/clinical-trials/ submitted by /u/Laker_Gev [link] [comments]
https://www.reddit.com/r/weedstocks/comments/8jnfh6/hvtv_hrvof_ptl_anticipates_b...
05/10/2018 - 12:42pm
ABBV
Exploring the Key Aspects of AbbVie’s Research Pipeline
(Development, Exploring, Investments, Research) AbbVie (ABBV) expects a number of regulatory submissions and key data readouts from its clinical trials over the next 12 months. The company’s research pipeline currently includes more than 60 compounds in clinical development, either individually or under collaboration and licensing agreements. It’s focused on specialties such as immunology, oncology, neurology, and targeted investments in cystic fibrosis and women’s health.
https://finance.yahoo.com/m/4050ac47-757e-3fc2-8d86-2d18379890b5/exploring-the-k...
03/10/2018 - 8:04pm
ASX:CMY
Sleeper picks/undervalued ones
(Branding, Financing, Insurance Companies, Management, Marketing) What are your personal sleeper/unloved picks? Looking around I see APH, TBP, TGIF (to name my personal favs)not getting the recognition they deserve. APH is already profitable, not overly diluted and has so much grow space but just aren't as "sexy" with the marketing as ACB and WEED. Acquired NUU and broken coast which gives them a huge global footprint in markets the other big 2 aren't even into yet. In terms of grow space they are right up there with 320,000kgs lined up eventually. TBP has a 41% stake in an ACMPR producer in Quebec along with the multiple clinical trials they have going on for them (with insurance companies covering the cost of the medicine now). Not to mention they just finished financing at 1$ for 11 million. TGIF well their in the city of sin which runs 45 million visitors a year looking to party and they have solid branding and good management. Mind you, I feel like they are a little short on the grow space if they really wanted to take over the market...
https://www.reddit.com/r/weedstocks/comments/83jhjr/sleeper_picksundervalued_one...
06/06/2017 - 4:34pm
3 Takeaways From Monday's ASCO Meetings: Puma Biotech, Incyte, Celgene
(Research) The American Society of Clinical Oncology’s annual meeting ended Tuesday. The event was filled with updates on clinical trials and research. Credit Suisse analyst Alethia Young released her key findings ...
https://finance.yahoo.com/news/3-takeaways-mondays-asco-meetings-203408835.html
06/04/2017 - 6:18pm
Review Identifies 140 Controlled Clinical Trials Related to Cannabis
(Cannabis) Scientists have conducted over 140 controlled clinical trials since 1975 assessing the safety and efficacy of whole-plant cannabis or specific ...
http://www.thedailychronic.net/2017/73255/review-identifies-140-controlled-clini...
05/31/2017 - 7:15am
Dramatic Surge in Very Low Nicotine Tobacco Clinical Trials and Science
(Cigarettes, Science, Tobacco) 22nd Century Group, Inc. announced today that there has been a dramatic surge in the number of publications relating to the Company’s proprietary Very Low Nicotine cigarettes.
https://finance.yahoo.com/news/dramatic-surge-very-low-nicotine-111500081.html?....
05/08/2017 - 3:16pm
Cannevert Presses On To Its Goal Of Clinical Trials
() submitted by /u/Adrenalize_ [link] [comments]
https://www.reddit.com/r/weedstocks/comments/6a090z/cannevert_presses_on_to_its_...
05/08/2017 - 3:16pm
Cannevert Presses On To Its Goal Of Clinical Trials - Veritas Pharma Inc
() submitted by /u/Adrenalize_ [link] [comments]
https://www.reddit.com/r/weedstocks/comments/6a090z/cannevert_presses_on_to_its_...
04/25/2017 - 9:28am
Kalytera Identifies Sites for Planned GvHD Clinical Trials; Company’s Research Gains Support at EBMT 2017
(Research) submitted by /u/sanghs [link] [comments]
https://www.reddit.com/r/weedstocks/comments/67gj6h/kalytera_identifies_sites_fo...
09/30/2015 - 1:38pm
Cannabis oil shows early promise in Georgia clinical trials
(Cannabis) Atlanta Journal Constitution Cannabis oil shows early promise in Georgia clinical trials Atlanta Journal Constitution Georgia-based clinical trials have shown early promise in using cannabis oil to treatment epileptic seizures, although researchers said they won't know for sure until at least the end of next year what strides they have made in the study of medical ... and more »
http://www.ajc.com/news/news/state-regional-govt-politics/cannabis-oil-shows-ear...
08/11/2015 - 1:29pm
America's Weed Rush
(Cannabis) America's Weed Rush - Clinical trials for cannabis: Docs weigh in on Epidiolex TriValley Central Bottles line the shelves in the lab of Dr. Eric Marsh, assistant professor of neurology and pediatrics and attending physician at the Children's Hospital of Philadelphia. Posted: Tuesday, August 11, 2015 10:00 am | Updated: 10:00 am, Tue Aug 11, 2015.
http://www.trivalleycentral.com/san_tan_valley_sentinel/health_and_wellness/amer...
08/06/2015 - 10:39am
CNS-focused US cannabis patch company raises $42M in IPO
(Cannabis) BioPharma Dive CNS-focused US cannabis patch company raises $42M in IPO BioPharma Dive PA-based Zynerba plans to move into clinical trials with cannibinoid-laced transdermal patches (ZYN001 and ZYN002) for treatment of various central nervous system (CNS) diseases. The company has raised $42 million in an IPO to help fund its ambitions. and more »
http://www.biopharmadive.com/news/cns-focused-us-cannabis-patch-company-raises-4...
07/27/2015 - 7:55pm
First Australian medical cannabis clinical trial greenlighted in NSW ...
(Cannabis, Medical Marijuana) Government News First Australian medical cannabis clinical trial greenlighted in NSW ... Government News NSW will be the first Australian state or territory to conduct medicinal cannabis clinical trials for terminally ill adults with cancer after Premier Mike Baird gave the go-ahead to researchers at UNSW. The NSW Government has committed $9 million to ... and more »
http://www.governmentnews.com.au/2015/07/first-australian-medical-cannabis-clini...
07/27/2015 - 1:46am
Queensland to wait until 2016 to begin trial of medical cannabis ...
(Cannabis, Medical Marijuana, Research) Queensland to wait until 2016 to begin trial of medical cannabis ... The Daily Telegraph CLINICAL trials of medicinal cannabis are not expected to begin in Queensland until next year. But Health Minister Cameron Dick said he had asked his department to look into the research gathered internationally in a bid to fast-track the move. It ... and more »
http://www.dailytelegraph.com.au/news/queensland-to-wait-until-2016-to-begin-tri...
07/21/2015 - 12:50pm
Change in the Air: Liz Warren Leads Group of Senators Pushing for Big Change ...
(Cannabis, Medical Marijuana) AlterNet Change in the Air: Liz Warren Leads Group of Senators Pushing for Big Change ... AlterNet Specifically, the senators are asking federal health officials to conduct “large-scale clinical trials” involving patients residing in legal medical cannabis states. The senators also request that the feds to provide better support, including financial ...
http://www.alternet.org/drugs/change-air-liz-warren-leads-group-senators-pushing...